Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial
Titel:
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial
Auteur:
Seaton, Kelly E Paez, Carmen A Yu, Chenchen Karuna, Shelly T Gamble, Theresa Miner, Maurine D Heptinstall, Jack Zhang, Lu Gao, Fei Yacovone, Margaret Spiegel, Hans Dumond, Julie B Anderson, Maija Piwowar-Manning, Estelle Dye, Bonnie Tindale, India Proulx-Burns, Lori Trahey, Meg Takuva, Simbarashe Takalani, Azwidihwi Bailey, Veronique C Kalams, Spyros A Scott, Hyman Mkhize, Nonhlanhla N Weiner, Joshua A Ackerman, Margaret E McElrath, M Juliana Pensiero, Michael Barouch, Dan H Montefiori, David Tomaras, Georgia D Corey, Lawrence Cohen, Myron S Huang, Yunda Mahomed, Sharana Siegel, Marc Kelley, Colleen F